Otter Tail (OTTR) Q3 2025 Earnings Transcript

Otter Tail reported Q3 diluted EPS of $1.86, down 8% year over year, but raised 2025 guidance to $6.32-$6.62 from $6.26-$6.47 after Plastics outperformed expectations. Management also lifted long-term EPS growth to 7%-9% and total shareholder return targets to 10%-12%, while expanding its 5-year electric capital plan 35% to $1.9 billion. Regulatory activity remains a key catalyst, including a $44.8 million Minnesota rate case, a South Dakota interim rate hike of $5.7 million annually, and ongoing antitrust litigation risk.

Analysis

OTTR is quietly transitioning from a regulated utility plus cyclical cash generator into a more self-funding growth compounder, and the market may still be underestimating how much of the next leg is de-risked by the balance sheet. The updated capex plan and higher rate-base trajectory matter less for headline growth than for duration: with roughly 90% recovery through existing rates/riders, the company is effectively converting regulatory lag into a lower-volatility earnings stream while preserving optionality from incremental load additions.

The bigger second-order effect is that plastics normalization is becoming a financing source rather than an earnings anchor. As PVC margins compress, the market will likely focus on near-term EPS pressure, but the volume from Vinyltech expansion plus lower input costs suggests cash generation is less fragile than the reported earnings profile implies. That creates a subtle valuation asymmetry: downside is cushioned by utility visibility, while upside comes from any faster-than-expected reset in plastics pricing or a delayed manufacturing trough.

The main risks are regulatory slippage and timing mismatch, not economics. Minnesota and South Dakota rate cases can easily turn from catalysts into stock-bond style overhangs if approval is delayed into 2026, while the large-load contribution is likely to disappoint momentum investors because the contract structure is intentionally interruptible and capital-light. Litigation is the more asymmetric tail risk: it is not an earnings issue today, but a dismissal denial or broader discovery path could compress the utility-quality multiple by raising governance and contingent-liability discounts.

Consensus appears to be treating OTTR as a sleepy utility when it is really a balance-sheet-driven capital allocator with embedded cyclical optionality. The market may also be too anchored to the current plastics downturn; if 2028 normalization proves even modestly better than management’s conservative framing, the equity can rerate on both higher earnings and lower perceived cyclicality. In that sense, the stock is more attractive on pullbacks than on momentum, because the setup improves as near-term plastics weakness creates a better entry while the regulated growth path remains intact.

Key Decisions for Investors

• Long OTTR on a 3-6 month horizon if the stock trades off on plastics margin compression; risk/reward favors buying weakness because utility growth visibility and no-equity funding reduce fundamental downside.
• Pair trade: long OTTR / short a higher-beta cyclical industrial or materials name with similar earnings sensitivity to end-market demand; OTTR’s regulated earnings base should outperform if macro data softens further over the next 2-4 quarters.
• Sell downside puts on OTTR into post-earnings volatility if implied move overstates litigation/regulatory risk; the stock’s cash-flow support and guidance raise create a favorable premium-collection setup.
• Avoid chasing the stock after rate-case headlines; wait for confirmation on Minnesota procedural milestones in 1H26, since approval timing—not ultimate economics—is the key catalyst risk.
• If legal headlines worsen, hedge with a small short-dated OTTR call overwrite or put spread for 1-3 months; the stock is unlikely to rerate higher while antitrust uncertainty is unresolved.